Overview

Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
We want to assess whether "how and when" one takes sleep medication results in similar or different outcomes with respect to symptom relief. We also want to know whether taking medication for a period of time provides continued benefit once the medication is stopped.
Phase:
Phase 4
Details
Lead Sponsor:
University of Rochester
Collaborator:
Sanofi-Synthelabo
Treatments:
Zolpidem